Open Access
Numéro
Med Sci (Paris)
Volume 38, Numéro 4, Avril 2022
Page(s) 351 - 358
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2022038
Publié en ligne 29 avril 2022
  1. Serafini T, Kennedy TE, Galko MJ, et al. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 1994 ; 78 : 409–424. [CrossRef] [PubMed] [Google Scholar]
  2. Rajasekharan S, Kennedy TE. The netrin protein family. Genome Biol 2009 ; 10 : 239. [CrossRef] [PubMed] [Google Scholar]
  3. Delloye-Bourgeois C, Goldschneider D, Paradisi A, et al. Nucleolar localization of a netrin-1 isoform enhances tumor cell proliferation. Sci Signal 2012; 5 : ra57. [CrossRef] [PubMed] [Google Scholar]
  4. Negulescu A-M, Mehlen P. Dependence receptors - the dark side awakens. FEBS J 2018 ; 285 : 3909–3924. [CrossRef] [PubMed] [Google Scholar]
  5. Grandin M, Meier M, Delcros JG, et al. Structural Decoding of the Netrin-1/UNC5 Interaction and its Therapeutical Implications in Cancers. Cancer Cell 2016 ; 29 : 173–185. [CrossRef] [PubMed] [Google Scholar]
  6. Liu G, Li W, Wang L, et al. DSCAM functions as a netrin receptor in commissural axon pathfinding. Proc Natl Acad Sci U S A 2009 ; 106 : 2951–2956. [CrossRef] [PubMed] [Google Scholar]
  7. Tu T, Zhang C, Yan H, et al. CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development. Cell Res 2015 ; 25 : 275–287. [CrossRef] [PubMed] [Google Scholar]
  8. Stein E, Zou Y, Poo M, et al. Binding of DCC by netrin-1 to mediate axon guidance independent of adenosine A2B receptor activation. Science 2001 ; 291 : 1976–1982. [CrossRef] [PubMed] [Google Scholar]
  9. Stanco A, Szekeres C, Patel N, et al. Netrin-1-alpha3beta1 integrin interactions regulate the migration of interneurons through the cortical marginal zone. Proc Natl Acad Sci USA 2009 ; 106 : 7595–7600. [CrossRef] [PubMed] [Google Scholar]
  10. Matsumoto Y, Irie F, Inatani M, et al. Netrin-1/DCC signaling in commissural axon guidance requires cell-autonomous expression of heparan sulfate. J Neurosci 2007 ; 27 : 4342–4350. [CrossRef] [PubMed] [Google Scholar]
  11. Wang H, Boussouar A, Mazelin L, et al. The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor. Mol Cell 2018 ; 72 : 413–25e5. [Google Scholar]
  12. Mehlen P, Rama N. Nétrine-1 et guidage axonal - Signalisation et traduction asymétrique. Med Sci (Paris) 2007 ; 23 : 311–315. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. Castets M, Mehlen P. Netrin-1 role in angiogenesis: to be or not to be a pro-angiogenic factor?. Cell Cycle 2010 ; 9 : 1466–1471. [CrossRef] [PubMed] [Google Scholar]
  14. Brunet I, Gordon E, Han J, et al. Netrin-1 controls sympathetic arterial innervation. J Clin Invest 2014 ; 124 : 3230–3240. [CrossRef] [PubMed] [Google Scholar]
  15. Murray MJ. The Role of Netrins and Their Receptors in Epithelial Mesenchymal Plasticity during Development. Cells Tissues Organs 2017 ; 203 : 71–81. [CrossRef] [PubMed] [Google Scholar]
  16. Hardy H, Prendergast JG, Patel A, et al. Detailed analysis of chick optic fissure closure reveals Netrin-1 as an essential mediator of epithelial fusion. Elife 2019; 8. [Google Scholar]
  17. Schlegel M, Köhler D, Körner A, et al. The neuroimmune guidance cue netrin-1 controls resolution programs and promotes liver regeneration. Hepatology 2016 ; 63 : 1689–1705. [CrossRef] [PubMed] [Google Scholar]
  18. Tang T, Gao D, Yang X, et al. Exogenous Netrin-1 Inhibits Autophagy of Ischemic Brain Tissues and Hypoxic Neurons via PI3K/mTOR Pathway in Ischemic Stroke. J Stroke Cerebrovasc Dis 2019 ; 28 : 1338–1345. [CrossRef] [PubMed] [Google Scholar]
  19. Mehlen P, Lavial F. Le facteur nétrine-1 régule la reprogrammation cellulaire vers l’état pluripotent. Med Sci (Paris) 2016 ; 32 : 241–244. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  20. Mazelin L, Bernet A, Bonod-Bidaud C, et al. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 2004 ; 431 : 80–84. [CrossRef] [PubMed] [Google Scholar]
  21. Papanastasiou AD, Pampalakis G, Katsaros D, et al. Netrin-1 overexpression is predictive of ovarian malignancies. Oncotarget 2011 ; 2 : 363–367. [CrossRef] [PubMed] [Google Scholar]
  22. Grandin M, Mathot P, Devailly G, et al. Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference. EMBO Mol Med 2016 ; 8 : 863–877. [CrossRef] [PubMed] [Google Scholar]
  23. Kaufmann S, Kuphal S, Schubert T, et al. Functional implication of Netrin expression in malignant melanoma. Cell Oncol 2009 ; 31 : 415–422. [PubMed] [Google Scholar]
  24. Sanvoranart T, Supokawej A, Kheolamai P, et al. Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis. Tumour Biol 2016 ; 37 : 14949–14960. [CrossRef] [PubMed] [Google Scholar]
  25. Harter PN, Zinke J, Scholz A, et al. Netrin-1 Expression Is an Independent Prognostic Factor for Poor Patient Survival in Brain Metastases. PLoS One 2014 ; 9 : e92311. [CrossRef] [PubMed] [Google Scholar]
  26. Delloye-Bourgeois C, Fitamant J, Paradisi A, et al. Netrin-1 acts as a survival factor for aggressive neuroblastoma. J Exp Med 2009 ; 206 : 833–847. [CrossRef] [PubMed] [Google Scholar]
  27. Akino T, Han X, Nakayama H, et al. Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of patients with pediatric medulloblastoma. Cancer Res 2014 ; 74 : 3716–3726. [CrossRef] [PubMed] [Google Scholar]
  28. Delloye-Bourgeois C, Brambilla E, Coissieux M-M, et al. Interference with netrin-1 and tumor cell death in non-small cell lung cancer. J Natl Cancer Inst 2009 ; 101 : 237–247. [CrossRef] [PubMed] [Google Scholar]
  29. Ramesh G, Krawczeski CD, Woo JG, et al. Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2010 ; 5 : 395–401. [CrossRef] [PubMed] [Google Scholar]
  30. Link B-C, Reichelt U, Schreiber M, et al. Prognostic implications of netrin-1 expression and its receptors in patients with adenocarcinoma of the pancreas. Ann Surg Oncol 2007 ; 14 : 2591–2599. [CrossRef] [PubMed] [Google Scholar]
  31. Kefeli U, Yildirim ME, Aydin D, et al. Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment. Biomarkers 2012 ; 17 : 663–667. [CrossRef] [PubMed] [Google Scholar]
  32. Paradisi A, Maisse C, Coissieux MM, et al. Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc Natl Acad Sci USA 2009 ; 106 : 17146–17151. [CrossRef] [PubMed] [Google Scholar]
  33. Yin K, Dang S, Cui L, et al. Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity. Biochem Biophys Res Commun 2018 ; 496 : 76–82. [CrossRef] [PubMed] [Google Scholar]
  34. Broutier L, Creveaux M, Vial J, et al. Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas. EMBO Mol Med 2016 ; 8 : 96–104. [CrossRef] [PubMed] [Google Scholar]
  35. Chen H, Chen Q, Luo Q. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity. Exp Cell Res 2016 ; 349 : 302–309. [CrossRef] [PubMed] [Google Scholar]
  36. Jin X, Luan H, Chai H, et al. Netrin-1 interference potentiates epithelial-to-mesenchymal transition through the PI3K/AKT pathway under the hypoxic microenvironment conditions of non-small cell lung cancer. Int J Oncol 2019 ; 54 : 1457–1465. [PubMed] [Google Scholar]
  37. Han P, Fu Y, Liu J, et al. Netrin-1 promotes cell migration and invasion by down-regulation of BVES expression in human hepatocellular carcinoma. Am J Cancer Res 2015 ; 5 : 1396–1409. [PubMed] [Google Scholar]
  38. Yin K, Wang L, Zhang X, et al. Netrin-1 promotes gastric cancer cell proliferation and invasion via the receptor neogenin through PI3K/AKT signaling pathway. Oncotarget 2017 ; 8 : 51177–51189. [PubMed] [Google Scholar]
  39. Huang Q, Hua HW, Jiang F, et al. Netrin-1 promoted pancreatic cancer cell proliferation by upregulation of Mdm2. Tumour Biol 2014 ; 35 : 9927–9934. [CrossRef] [PubMed] [Google Scholar]
  40. Huyghe A, Furlan G, Ozmadenci D, et al. Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signalling. Nat Cell Biol 2020; 22 : 389–400. [CrossRef] [PubMed] [Google Scholar]
  41. Liu J, Li J. PKCα and Netrin-1/UNC5B positive feedback control in relation with chemical therapy in bladder cancer. Eur Rev Med Pharmacol Sci 2020; 24 : 1712–7. [PubMed] [Google Scholar]
  42. Zhang X, Cui P, Ding B, et al. Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction. Cancer Gene Ther 2018 ; 25 : 18–26. [CrossRef] [PubMed] [Google Scholar]
  43. Paradisi A, Maisse C, Bernet A, et al. NF-kappaB regulates netrin-1 expression and affects the conditional tumor suppressive activity of the netrin-1 receptors. Gastroenterology 2008 ; 135 : 1248–1257. [CrossRef] [PubMed] [Google Scholar]
  44. Lee S-J, Jung YH, Oh SY, et al. Netrin-1 induces MMP-12-dependent E-cadherin degradation via the distinct activation of PKCα and FAK/Fyn in promoting mesenchymal stem cell motility. Stem Cells Dev 2014 ; 23 : 1870–1882. [CrossRef] [PubMed] [Google Scholar]
  45. Ly NP, Komatsuzaki K, Fraser IP, et al. Netrin-1 inhibits leukocyte migration in vitro and in vivo. Proc Natl Acad Sci U S A 2005 ; 102 : 14729–14734. [CrossRef] [PubMed] [Google Scholar]
  46. Rosenberger P, Schwab JM, Mirakaj V, et al. Hypoxia-inducible factor-dependent induction of netrin-1 dampens inflammation caused by hypoxia. Nat Immunol 2009 ; 10 : 195–202. [CrossRef] [PubMed] [Google Scholar]
  47. van Gils JM, Derby MC, Fernandes LR, et al. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat Immunol 2012 ; 13 : 136–143. [CrossRef] [PubMed] [Google Scholar]
  48. Podjaski C, Alvarez JI, Bourbonniere L, et al. Netrin 1 regulates blood-brain barrier function and neuroinflammation. Brain 2015 ; 138 : 1598–1612. [CrossRef] [PubMed] [Google Scholar]
  49. Ramkhelawon B, Hennessy EJ, Ménager M, et al. Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity. Nat Med 2014 ; 20 : 377–384. [CrossRef] [PubMed] [Google Scholar]
  50. Sharma M, Schlegel M, Brown EJ, et al. Netrin-1 Alters Adipose Tissue Macrophage Fate and Function in Obesity. Immunometabolism 2019; 1. [Google Scholar]
  51. Sung P-J, Rama N, Imbach J, et al. Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity. Cancer Res 2019 ; 79 : 3651–3661. [CrossRef] [PubMed] [Google Scholar]
  52. Paradisi A, Creveaux M, Gibert B, et al. Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death. EMBO Mol Med 2013 ; 5 : 1821–1834. [CrossRef] [PubMed] [Google Scholar]
  53. Cassier P, Eberst L, Courbebaisse Y, et al. 439O : A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors. Annals of Oncology 2019 ; 30 : v159. [CrossRef] [Google Scholar]
  54. Bruikman CS, Zhang H, Kemper AM, et al. Netrin Family: Role for Protein Isoforms in Cancer. J Nucleic Acids 2019 ; 2019 : 3947123. [CrossRef] [Google Scholar]
  55. Nakayama H, Kusumoto C, Nakahara M, et al. Semaphorin 3F and Netrin-1: The Novel Function as a Regulator of Tumor Microenvironment. Front Physiol 2018 ; 9 : 1662. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.